{"id":"https://openalex.org/W2393798755","doi":null,"title":"[Effect of fenofibrate and metformin on lipotoxicity in OLETF rat kidney].","display_name":"[Effect of fenofibrate and metformin on lipotoxicity in OLETF rat kidney].","alternate_titles":[],"publication_year":2006,"publication_date":"2006-04-18","ids":{"openalex":"https://openalex.org/W2393798755","mag":"2393798755","pmid":"https://pubmed.ncbi.nlm.nih.gov/16617360"},"language":"zh","primary_location":{"id":"pmid:16617360","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16617360","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences","raw_type":"English Abstract"},"parent_works":[],"lineage":["https://openalex.org/W2393798755"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100391719","display_name":"Wei Wang","orcid":"https://orcid.org/0000-0001-7156-205X","observed_orcids":["https://orcid.org/0000-0001-7156-205X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wei Wang","raw_affiliation_strings":["Department of Endocrinology, Peaking University First Hospital, Beijing 100034, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology, Peaking University First Hospital, Beijing 100034, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100647240","display_name":"Xiaohui Guo","orcid":"https://orcid.org/0000-0002-5588-0995","observed_orcids":["https://orcid.org/0000-0002-5588-0995","https://orcid.org/0009-0001-7638-8078"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xiao-hui Guo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110366370","display_name":"Honghua Wu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hong-hua Wu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051023462","display_name":"Nian-hong Wang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nian-hong Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5016372105","display_name":"Xiu-shuang Xu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xiu-shuang Xu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"38","issue":"2","first_page":"170","last_page":"175"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.8393999934196472,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.8393999934196472,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.04050000011920929,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.012500000186264515,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fenofibrate","display_name":"fenofibrate","score":0.9819999933242798},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":1.0},{"id":"https://openalex.org/keywords/lipotoxicity","display_name":"lipotoxicity","score":0.8560000061988831},{"id":"https://openalex.org/keywords/oletf-rats","display_name":"OLETF rats","score":0.8209999799728394},{"id":"https://openalex.org/keywords/renal-lipid-metabolism","display_name":"renal lipid metabolism","score":0.7680000066757202},{"id":"https://openalex.org/keywords/srebp-1","display_name":"SREBP1","score":0.9549999833106995},{"id":"https://openalex.org/keywords/fatty-acid-synthase","display_name":"fatty acid synthase","score":0.9589999914169312},{"id":"https://openalex.org/keywords/acetyl-coa-carboxylase","display_name":"acetyl-CoA carboxylase","score":0.9900000095367432},{"id":"https://openalex.org/keywords/urinary-albumin","display_name":"urinary albumin","score":0.6480000019073486},{"id":"https://openalex.org/keywords/prediabetes","display_name":"prediabetes","score":0.9369999766349792},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.5879999995231628},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.46799999475479126},{"id":"https://openalex.org/keywords/hyperlipidemia","display_name":"hyperlipidemia","score":0.8830000162124634},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.8519999980926514}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8945834636688232},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.8800207376480103},{"id":"https://openalex.org/C2778110834","wikidata":"https://www.wikidata.org/wiki/Q419724","display_name":"Fenofibrate","level":2,"score":0.8327962160110474},{"id":"https://openalex.org/C44353895","wikidata":"https://www.wikidata.org/wiki/Q6556772","display_name":"Lipotoxicity","level":4,"score":0.6576908826828003},{"id":"https://openalex.org/C2779091943","wikidata":"https://www.wikidata.org/wiki/Q1079120","display_name":"Hyperlipidemia","level":3,"score":0.5823372602462769},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.5629667043685913},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.5380915999412537},{"id":"https://openalex.org/C2776125364","wikidata":"https://www.wikidata.org/wiki/Q169219","display_name":"Albumin","level":2,"score":0.5128915309906006},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5037450194358826},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.4745122790336609},{"id":"https://openalex.org/C4733338","wikidata":"https://www.wikidata.org/wiki/Q2792936","display_name":"Lipid metabolism","level":2,"score":0.43683716654777527},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3780067265033722},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.24567076563835144},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.24311962723731995},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.16783633828163147}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011345","descriptor_name":"Fenofibrate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020334","descriptor_name":"Rats, Inbred OLETF","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050356","descriptor_name":"Lipid Metabolism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051780","descriptor_name":"Sterol Regulatory Element Binding Protein 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:16617360","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16617360","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences","raw_type":"English Abstract"},{"id":"mag:2393798755","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16617360","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2380385092","https://openalex.org/W4402389733","https://openalex.org/W4406523324","https://openalex.org/W2003555400","https://openalex.org/W2041446873","https://openalex.org/W3104791224","https://openalex.org/W50549045","https://openalex.org/W1993529158","https://openalex.org/W4360976835"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"explore":[2],"the":[3,16,60,66,115,266],"possible":[4,298],"molecular":[5],"mechanism":[6],"of":[7,18,68,86,110,117,122,134,141,183,198,206,222,230,244,300],"abnormal":[8],"renal":[9,23,81,123,309],"lipid":[10,25],"metabolism":[11],"in":[12,80,91,126,154,251,262,279,286,311,325],"OLETF":[13,28,106,127,129,178,263,312],"rats,":[14,128],"and":[15,43,59,70,77,89,97,174,316],"effects":[17],"fenofibrate":[19,305],"or":[20,306],"metformin":[21,42,307],"on":[22],"local":[24],"metabolism.":[26],"METHODS:":[27],"rats":[29,48,107,130,179,202,226,264,313],"were":[30,49,57,62,83,93,101,148,273],"randomly":[31],"divided":[32],"into":[33],"three":[34],"groups:":[35],"one":[36,40,44],"treated":[37],"with":[38,41,103,151,276,292,304],"fenofibrate,":[39],"without":[45],"treatment.":[46],"LETO":[47,142],"used":[50],"as":[51],"age-matched":[52],"normal":[53],"controls.":[54],"The":[55,156],"animals":[56],"sacrificed":[58],"kidneys":[61],"obtained":[63],"respectively":[64],"at":[65,265],"age":[67],"17":[69],"30":[71],"weeks.":[72],"24-hour":[73,135,144,269],"urine":[74,136,145,270],"albumin":[75,137,146,271],"contents":[76,79,138,147,153,272,278],"TG":[78,152,277],"cortex":[82],"measured.The":[84],"levels":[85,133,182,205,229,254],"SREBP-1":[87,184,207,231,252,281,315],"protein":[88,185],"mRNA":[90,96,99,189,193,213,217,235,239,253],"kidney":[92,287,326],"measured.":[94],"FAS":[95,188,212,234],"ACC":[98,192,216,238],"expressions":[100],"measured":[102],"RT-PCR.":[104],"RESULTS:":[105],"showed":[108,131,180,203,227],"characters":[109,121],"obesity,":[111],"hyperglycemia,":[112],"hyperlipidemia.":[113],"At":[114],"end":[116],"thirty":[118],"weeks":[119],"clinical":[120],"damage":[124,260,310],"appeared":[125],"higher":[132,181],"than":[139,196,220,242],"those":[140,197,221,243],"rats.":[143],"correlated":[149,274],"positively":[150,275],"kidney.":[155,280],"partial":[157],"correlation":[158],"coefficient":[159],"was":[160,248,296],"0.870":[161],"(P":[162],"=":[163,210],"0.011)":[164],"by":[165,320],"controlling":[166],"for":[167,255],"body":[168],"weight,":[169],"serum":[170],"lipid,":[171],"blood":[172],"glucose":[173],"fasting":[175],"insulin":[176],"concentration.":[177],"(43.2%,":[186],"P<0.01),":[187,191,233,237],"(126.0%,":[190],"(72.3%,":[194],"P<0.01)":[195],"group":[199,223,245],"LETO.":[200],"OLETF/F":[201],"lower":[204,228],"(15.7%,":[208],"P":[209],"0.061),":[211],"(36.8%,":[214],"P<0.05),":[215],"(40.3%,":[218],"P<0.05)":[219,241],"OLETF.":[224,246],"OLETF/M":[225],"(19.3%,":[232],"(57.3%,":[236],"(22.5%,":[240],"There":[247],"no":[249],"difference":[250],"each":[256],"group.":[257],"CONCLUSION:":[258],"Renal":[259],"occurred":[261],"prediabetes":[267],"stage.":[268],"might":[282],"aggravate":[283],"fat":[284,293,323],"deposition":[285],"through":[288,314],"some":[289,317],"enzyme":[290,318],"associated":[291],"synthesis,":[294],"which":[295],"a":[297],"pathogenesis":[299],"diabetic":[301],"nephropathy.":[302],"Treatment":[303],"ameliorated":[308],"regulated":[319],"it":[321],"reduced":[322],"deposit":[324],"directly.":[327]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2393798755","counts_by_year":[{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
